Fifty-two week follow-up safety and effectiveness results of dupilumab treatment of moderate-to-severe atopic dermatitis from a retrospective, multicentric series
FI: 1,74
Type: Article
Artículo original
Year: 2019
Writers
Ruiz-Villaverde, R; Dominguez-Cruz, J; Closet-Hita, JC; Martinez-Pilar, L; Alcantara-Luna, S; Pereyra-Rodriguez, JJ
Magazine
Title: DERMATOLOGIC THERAPY
Quartile
- Q3